Advertisement

Pharmaceutical Research

, Volume 8, Issue 2, pp 217–221 | Cite as

Nebulization of Liposomes. II. The Effects of Size and Modeling of Solute Release Profiles

  • Ralph W. Niven
  • Melissa Speer
  • Hans Schreier
Article

Abstract

A series of carboxyfluorescein (CF)-containing multilamellar vesicle (MLV) dispersions was prepared and extruded through polycarbonate membranes ranging in size from 0.2 to 5 µm. Vesicle dispersions were nebulized for 80 min using a Collison nebulizer, and the release of CF was monitored during nebulization. Solute retention was dependent upon the size of the vesicles and leakage ranged from 7.9 ± 0.4% (N = 3) for vesicles extruded through 0.2-µm filters to 76.8 ± 5.9% (N = 3) for liposomes that were not filtered. Solute release profiles obtained over ≥420-min nebulization periods conformed to a two-compartment kinetic model and exhibited a “fast” initial phase (kl = 0.052 ± 0.0043) followed by a “slow” terminal phase (k2 = 0.0034 ± 0.00018). The results show that CF retention can be increased by nebulizing small vesicles and modeling suggests that the rate of CF leakage from the bilayers is faster than from the core of the liposomes.

aerosols carboxyfluorescein liposomes nebulizers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    R. W. Niven and H. Schreier. Nebulization of liposomes. I. Effects of lipid composition. Pharm. Res. 7:1127–1133 (1990).Google Scholar
  2. 2.
    B. E. Gilbert, H. R. Six, S. Z. Wilson, P. R. Wyde, and V. Knight. Small particle aerosols of enviroxime-containing liposomes. Antivir. Res. 9:355–365 (1988).Google Scholar
  3. 3.
    T. T. Mercer, M. I. Tillery, and H. Y. Chow. Operating characteristics of some compressed air nebulizers. Am. Ind. Hyg. Assoc. J. 29:66–78 (1968).Google Scholar
  4. 4.
    H. W. Young, J. W. Dominik, J. S. Walker, and E. W. Larson. Continuous aerosol therapy system using a modified Collison nebulizer. J. Clin. Microbiol. 5:131–136 (1977).Google Scholar
  5. 5.
    C. O. Callaghan, A. R. Clarke, and A. D. Milner. Inaccurate calculation of drug output from nebulisers. Eur. J. Pediat. 148:473–474 (1989).Google Scholar
  6. 6.
    J. A. Wood, R. S. E. Wilson, and C. Bray. Changes in salbutamol concentration in the reservoir solution of a jet nebulizer. Br. J. Dis. Chest 80:164–169 (1986).Google Scholar
  7. 7.
    K. R. May. The Collison nebulizer: Description, performance and application. J. Aerosol Sci. 4:235–243 (1973).Google Scholar
  8. 8.
    L. D. Mayer, M. B. Bally, M. J. Hope, and P. R. Cullis. Techniques for encapsulating bioactive agents into liposomes. Chem. Phys. Lipids. 40:333–345 (1986).Google Scholar
  9. 9.
    S. P. Newman, P. G. D. Pellow, M. M. Clay, and S.W. Clarke. Evaluation of jet nebulizers for use with gentamicin solution. Thorax 40:671–676 (1985).Google Scholar
  10. 10.
    R. V. Lourenço and E. Cotromanes. Clinical aerosols. I. Characterization of aerosols and their diagnostic uses. Arch. Intern. Med. 142:2163–2172 (1982).Google Scholar
  11. 11.
    K. M. G. Taylor, G. Taylor, I. W. Kellaway, and J. Stevens. The stability of liposomes to nebulization. Int. J. Pharm. 58:57–61 (1990).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • Ralph W. Niven
    • 1
  • Melissa Speer
    • 1
  • Hans Schreier
    • 1
  1. 1.University of FloridaGainesville

Personalised recommendations